DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Arrow Greentech Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 53 min ago·13 Oct 2026, 8:43 am

Arrow Greentech

Arrow Greentech Limited has informed stock exchanges that it has obtained a Certificate under the SEBI (Depositories and Participants) Regulations, 2018. This compliance document confirms that the company meets the regulatory requirements for its depository operations.

This regulatory milestone is a routine procedural update for the company. For investors, it signals that Arrow Greentech is maintaining proper governance standards in its financial and shareholding processes. It does not indicate a change in the company's core business or financial performance.

Investors should monitor the company's future quarterly results to see if this regulatory compliance positively impacts its operational efficiency or market standing. Currently, this news is a neutral update regarding the company's adherence to regulatory norms.